These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2575137)

  • 1. Evaluation of human and simian immunodeficiency virus plaque and neutralization assays.
    McKeating JA; McKnight A; McIntosh K; Clapham PR; Mulder C; Weiss RA
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3327-33. PubMed ID: 2575137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque-reduction assays for human and simian immunodeficiency virus neutralization.
    Nordqvist A; Fenyö EM
    Methods Mol Biol; 2005; 304():273-85. PubMed ID: 16061983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhesus monkey macrophages infected with simian immunodeficiency virus cause rapid lysis of CD4-bearing lymphocytes.
    McEntee MF; Sharma DP; Zink MC; Adams RJ; Flexner C; Clements JE; Narayan O
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():317-24. PubMed ID: 1671581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates.
    Chackerian B; Haigwood NL; Overbaugh J
    Virology; 1995 Nov; 213(2):386-94. PubMed ID: 7491763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral and cellular gene expression in CD4+ human lymphoid cell lines infected by the simian immunodeficiency virus, SIV/Mne.
    Agy MB; Foy K; Gale MJ; Benveniste RE; Clark EA; Katze MG
    Virology; 1991 Jul; 183(1):170-80. PubMed ID: 1675822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus.
    Clapham PR; Blanc D; Weiss RA
    Virology; 1991 Apr; 181(2):703-15. PubMed ID: 1673040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential neutralizing capacity to different human immunodeficiency virus (HIV) isolates by a rabbit antiserum against LAV: sensitive assays with HTLV-I-positive MT-4 cells.
    Yoshiyama H; Nakashima H; Kobayashi S; Yamamoto N
    AIDS Res Hum Retroviruses; 1988 Apr; 4(2):91-8. PubMed ID: 3284555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
    Spear GT; Takefman DM; Sullivan BL; Landay AL; Jennings MB; Carlson JR
    Virology; 1993 Aug; 195(2):475-80. PubMed ID: 8337824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT4 cells.
    Rey F; Barré-Sinoussi F; Schmidtmayerova H; Chermann JC
    J Virol Methods; 1987 Jun; 16(3):239-49. PubMed ID: 3477567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectin.
    Marzi A; Mitchell DA; Chaipan C; Fisch T; Doms RW; Carrington M; Desrosiers RC; Pöhlmann S
    Virology; 2007 Nov; 368(2):322-30. PubMed ID: 17659761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MT-4 plaque formation can distinguish cytopathic subtypes of the human immunodeficiency virus (HIV).
    Tateno M; Levy JA
    Virology; 1988 Nov; 167(1):299-301. PubMed ID: 3263731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new cell line-based neutralization assay for primary HIV type 1 isolates.
    Shi Y; Albert J; Francis G; Holmes H; Fenyö EM
    AIDS Res Hum Retroviruses; 2002 Sep; 18(13):957-67. PubMed ID: 12230938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of a WHO workshop on the measurement and significance of neutralizing antibody to HIV and SIV. London, 3-5 October 1988.
    World Health Organization Global Programme on AIDS
    AIDS; 1990 Mar; 4(3):269-75. PubMed ID: 2161671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electron microscopic investigation of CD4+ lymphocyte cell line C8166 after infection with simian immunodeficiency virus (SIV)].
    Kaup FJ; Bingger K; Mätz-Rensing K; Stahl-Hennig C; Schneider T; Hofmann P
    Dtsch Tierarztl Wochenschr; 2003 Apr; 110(4):142-6. PubMed ID: 12756953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. World Health Organization workshop on the measurement and significance of neutralizing antibody to HIV and SIV.
    Weber J; Schild G
    AIDS; 1989 Feb; 3(2):109-11. PubMed ID: 2496719
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.
    Kawada M; Tsukamoto T; Yamamoto H; Takeda A; Igarashi H; Watkins DI; Matano T
    J Virol; 2007 May; 81(10):5202-11. PubMed ID: 17344296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies.
    Jaspan HB; Robinson JE; Amedee AM; Van Dyke RB; Garry RF
    J Clin Virol; 2004 Nov; 31(3):190-7. PubMed ID: 15465411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic dendritic-cell vaccine for simian AIDS.
    Lu W; Wu X; Lu Y; Guo W; Andrieu JM
    Nat Med; 2003 Jan; 9(1):27-32. PubMed ID: 12496959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro assays for detecting neutralizing and fusion-inhibiting antibodies to SIVMAC251.
    Langlois AJ; Weinhold KJ; Matthews TJ; Bolognesi DP
    AIDS Res Hum Retroviruses; 1991 Aug; 7(8):713-20. PubMed ID: 1718347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.